AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sopharma AD

Earnings Release Sep 5, 2019

2543_rns_2019-09-05_5c3a34e0-a000-4b09-9b7c-02b651cd7558.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Current report No. 39 / 2019 Dated September 5, 2019

NOTIFICATION

Sopharma AD (the "Company") notifies that for August 2019 the Company recorded a decrease in sales of 3% compared to the same month of 2018, incl. 2% decrease in sales for the domestic market and 3% decrease in export sales.

In the first eight months of 2019 the revenues from sales of production decreased by 1% compared to the same period of 2018, incl. 9% decrease in domestic sales and 4% increase of export sales.

Signatures of individuals authorized to represent the Company:

Ognian Donev

Talk to a Data Expert

Have a question? We'll get back to you promptly.